The PML isoform IV is a negative regulator of nuclear EGFR’s transcriptional activity in lung cancer (original) (raw)
Related papers
Journal of Structural Biology, 2007
The Effects of EGFR Exon 19 747–750 Deletion on the Risk of Developing Lung Cancer
Medical Science and Discovery, 2019
Comprehensive molecular profiling of lung adenocarcinoma
2014
Predictive biomarkers in the management of EGFR mutant lung cancer
Annals of the New York Academy of Sciences, 2010
EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
International Journal of Medical Sciences, 2000
Jurnal Respirasi, 2023
AIF-regulated oxidative phosphorylation supports lung cancer development
Cell Research, 2019
EGFR genomic alterations in cancer: prognostic and predictive values
Frontiers in Bioscience, 2009
Differentially expressed and activated proteins associated with non small cell lung cancer tissues
Respiratory Research, 2015
Joint Transcriptomic Analysis of Lung Cancer and Other Lung Diseases
Frontiers in Genetics, 2019
EGFR and KRAS mutation coexistence in lung adenocarcinomas
Diagnostic Pathology, 2015
Genomic landscape of lung cancer in the young
Frontiers in Oncology, 2022
Epidermal Growth Factor 62229-50-9
Sax's Dangerous Properties of Industrial Materials, 2004
Cytoplasmic EGFR Staining and Gene Amplification in Glottic Cancer
Applied Immunohistochemistry & Molecular Morphology, 2014
The EGFRvIII transcriptome in glioblastoma, a meta-omics analysis
WFNOS 2022 Abstract Book, 2022
Bronchial-pulmonary adenocarcinoma subtyping relates with different molecular pathways
Revista Portuguesa de Pneumologia, 2014
Lung cancer and Toll-like receptors
Cancer Immunology, Immunotherapy, 2011
The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis
Neuro-oncology, 2021
Targeted therapies in non-small cell lung cancer
Cancer Imaging, 2008
Anti-tissue factor short hairpin RNA inhibits breast cancer growth in vivo
Breast Cancer Research and Treatment, 2010
Oncotarget, 2016
Identification of Piwil2-Like (PL2L) Proteins that Promote Tumorigenesis
PLoS ONE, 2010
Targeting mTOR Signaling for Lung Cancer Therapy
Journal of Thoracic Oncology, 2006
Evaluation of Prognostic Factors for Survival in Stage I Non-small Cell Lung Carcinoma
Erciyes medical journal, 2017
Gene expression in inherited breast cancer
Advances in Cancer Research, 2002